Proteomic analysis on multi-drug resistant cells HL-60/DOX of acute myeloblastic leukemia

Chinese Journal of Physiology

Volumn 48, Issue 3, 2005, Pages 115-120

  Chen, Chun Yan ^a,b   Jia, Ji Hui ^a   Zhang, Mao Xiu ^a   Meng, Yue Sheng ^b   Kong, De Xiao ^a,b   Pan, Xiang Lin ^b   Yu, Xiu Ping ^a  

^a SHANDONG UNIVERSITY   (China)

^b THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

Author keywords

Leukemia; Multi drug resistance; Myeloblastic; Proteomics

Indexed keywords

ANKYRIN; CHIMERIN; ENZYME PRECURSOR; INORGANIC PYROPHOSPHATASE; ISOMERASE; METALLOTHIONEIN; MULTIDRUG RESISTANCE PROTEIN; PROTEASOME; PURINE NUCLEOSIDE PHOSPHORYLASE; SUPEROXIDE DISMUTASE; WNT PROTEIN;

ACUTE MYELOBLASTIC LEUKEMIA; AMINO ACID SEQUENCE; ARTICLE; CANCER CELL CULTURE; CELL METABOLISM; CONTROLLED STUDY; DATA BASE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; INTERNET; LEUKEMIA; LEUKEMIA CELL; LEUKEMOGENESIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PEPTIDE MAPPING; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 24944483028     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Baker, E.K. and El-Osta, A. The rise of DNA methylation and the importance of chromatin on multidrug resistance in cancer. Exp. Cell Res. 290: 177-194, 2003.
2. Chen, G., Gharib, T.G., Huang, C.C., Thomas, D.G., Shedden, K.A., Taylor, J.M., Kardia, S.L., Misek, D.E., Giordano, T.J., Iannettoni, M.D., Orringer, M.B., Hanash, S.M. and Beer, D.G. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin. Cancer Res. 8: 2298-2305, 2002.
3. Cress, A.E. and Dalton, W.S. Multiple drug resistance and intermediate filaments. Cancer Metast. Rev. 15: 499-506, 1996.
4. Fanelli, M., Minucci, S., Gelmetti, V., Nervi, C., Gambacorti-Passerini, C. and Pelicci, P.G. Constitutive degradation of PML/ RARalpha through the proteasome pathway mediates retinoic acid resistance. Blood 93: 1477-1481, 1999.
5. Foresman, M.D., Nelson, D.M. and McIvor, R.S. Correction of purine nucleoside phosphorylase deficiency by retroviral-mediated gene transfer in mouse S49 T cell lymphoma: a model for gene therapy of T cell immunodeficiency. Hum. Gene. Ther. 3: 625-631, 1992.
6. Gong, Y.P., Liu, T., Jia, Y.Q., Qin, L., Deng, C.Q. and Yang, R.Y. Comparison of Pgp- and MRP-mediated multidrug resistance in leukemia cell lines. Int. J. Hematol. 75: 154-160, 2002.
7. Greasley, S.E., Horton P., Ramcharan J., Beardsley G.P., Benkovic S.J. and Wilson I.A. Crystal structure of a bifunctional transformylase and cyclohydrolase enzyme in purine biosynthesis. Nat. Struct. Biol. 8: 402-406, 2001.
8. Hasegawa, K., Wang, Z., Inagaki, M. and Carr, B.I. Characterization of a human hepatoma cell line with acquired resistance to growth inhibition by transforming growth factor beta 1 (TGF-beta 1). In Vitro Cell Dev. Biol. Anim. 31: 55-61, 1995.
9. Hirose, M., Hosoi, E., Hamano, S. and Jalili, A. Multidrug resistance in hematological malignancy. J. Med. Invest. 50: 126-135, 2003.
10. Hutter, G. and Sinha, P. Proteomics for studying cancer cells and the development of chemoresistance. Proteomics. 1: 1233-1248, 2001.
11. Kalinina, E.V., Saprin, A.N., Solomka, V.S., Shcherbak, N.P., Chermnykh, N.S. and Piruzian, L.A. Role of the antioxidant system and redox-dependent regulation of transcription factors bcl-2 and p53 in forming resistance of human K562 erythroleukemia cells to doxorubicin. Vopr. Onkol. 47: 595-600, 2001.
12. Kappelmayer, J., Simon, A., Kiss, F. and Hevessy, Z. Progress in defining multidrug resistance in leukemia. Expert. Rev. Mol. Diagn. 4: 209-217, 2004
13. Katoh, M. Expression and regulation of WNT1 in human cancer: up-regulation of WNT1 by beta-estradiol in MCF-7 cells. Int. J. Oncol. 22: 209-212, 2003.
14. Khan, J. Genomic & proteomic technological advances in cancer research. Pharmacogenomics 4: 245-249, 2003.
15. Kozma, R., Ahmed, S., Best, A., Lim, L., Kozma, R., Ahmed, S., Best, A. and Lim, L. The GTPase-activating protein n-chimaerin cooperates with Rac1 and Cdc42Hs to induce the formation of lamellipodia and filopodia. Mol. Cell Biol. 16: 5069-5080, 1996.
16. Leonard, G.D., Fojo, T. and Bates, S.E. The role of ABC transporters in clinical practice. Oncologist 8: 411-424, 2003.
17. Motoji, T., Motomura, S. and Wang, Y.H. Multidrug resistance of acute leukemia and a strategy to overcome it. Int. J. Hematol. 72: 418-424, 2000.
18. Okamoto, P.M., Gamby, C., Wells, D., Fallon, J. and Vallee, R.B. Dynamin isoform-specific interaction with the shank/ProSAP scaffolding proteins of the postsynaptic density and actin cytoskeleton. J. Biol. Chem. 276: 48458-48465, 2001.
19. Pilch, B., Allemand, E., Facompre, M., Bailly, C., Riou, J.F., Soret, J. and Tazi, J. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506. Cancer Res. 61: 6876-6884, 2001.
20. Plasschaert, S.L., Van Der Kolk, D.M., De Bont, E.S., Vellenga, E., Kamps, W.A. and De Vries, E.G. Breast cancer resistance protein (BCRP) in acute leukemia. Leuk. Lymphoma. 45: 649-654, 2004.
21. Poland, J., Schadendorf, D., Lage, H., Schnolzer, M., Celis, J.E. and Sinha, P. Study of therapy resistance in cancer cells with functional proteome analysis. Clin. Chem. Lab Med. 40: 221-234, 2002.
22. Sinha, P., Poland, J., Kohl, S., Schnolzer, M., Helmbach, H., Hutter, G., Lage, H. and Schadendorf, D. Study of the development of chemoresistance in melanoma cell lines using proteome analysis. Electrophoresis 24: 2386-2404, 2003.
23. Spataro, V., Simmen, K. and Realini, C.A. The essential 26S proteasome subunit Rpn11 confers multidrug resistance to mammalian cells. Anticancer Res. 22: 3905-3909, 2002.
24. Tager, M., Kroning, H., Thiel, U. and Ansorge, S. Membrane-bound proteindisulfide isomerase (PDI) is involved in regulation of surface expression of thiols and drug sensitivity of B-CLL cells. Exp. Hematol. 25: 601-607, 1997.
25. Tsangaris, G.T,, Vamvoukakis, J., Politis, I., Kattamis, A.C. and Tzortzatou-Stathopoulou, F. Metallothionein expression prevents apoptosis. II: Evaluation of the role of metallothionein expression on the chemotherapy-induced apoptosis during the treatment of acute leukemia. Anticancer Res. 20: 4407-4411, 2000.